We celebrated Pride Month by learning how organizations like OUTBio and other allies across life sciences, biopharma and health care industries are highlighting the needs of HIV patients. Enormous strides in treatment have been made since the HIV Epidemic began 40 years ago. With many misconceptions around HIV, where are we with drug development and discovery for treatments? And how has pricing and drug regulation hindered and progressed access to treatment?
We held a fireside chat with fellow allies including Heath Ingram, representing OUTBio, Sean Dickson, SVP Pharmaceutical Policy and Strategy, and NYC famed doctor & MSNBC medical commentator, and Medical Director of Housing Works Dr. Lipi Roy.
In partnership with:
Tuesday Talks: Celebrating Pride Month
When: Tuesday, June 27, 5:30 pm – 7:30 pm Where: The rooftop at Cure. 345 Park Avenue South, New York, NY 10010
Topic: A fireside chat with fellow allies including Heath Ingram, representing OUTBio, Sean Dickson, SVP Pharmaceutical Policy and Strategy, and NYC famed doctor & MSNBC medical commentator, and Medical Director of Housing Works Dr. Lipi Roy.
About Dr. Lipi Roy
Dr. Lipi Roy is an internal medicine and addiction medicine physician, speaker, writer, and sought-after media personality. As an MSNBC and NBC News Medical Contributor, Dr. Roy has been on hundreds of nationwide appearances discussing health issues. Dr. Roy’s leadership experience spans academia, clinical medicine, media, homeless health, social and criminal justice, and public speaking. She serves as Medical Director of COVID Isolation and Quarantine Sites at Housing Works in New York City and hosts Health, Humor & Harmony on YouTube. As the former Chief of Addiction Medicine for New York City jails, including Rikers Island, Dr. Roy oversaw substance use treatment and recovery efforts at the nation’s 2nd-largest jail complex. Previously, she was a primary care doctor to Boston’s vulnerable homeless population, among whom drug overdose was the leading cause of death. She was also an attending physician at Massachusetts General Hospital and faculty at Harvard Medical School, where she taught Clinical Nutrition and The Healer’s Art. Dr. Roy completed her medical and master’s in public health degrees at Tulane University in New Orleans, followed by residency training in internal medicine at Duke University Medical Center. Dr. Roy is a strong advocate for public service. In addition to caring for incarcerated and homeless men and women, she has served the underserved in Nicaragua, India, and New Orleans residents affected by Hurricane Katrina. Dr. Roy has also provided medical relief to earthquake victims in Haiti and volunteered in the medical tent at the Boston Marathon.
About Heath Ingram
Heath Ingram is an attorney at Goodwin Procter LLP in the Life Sciences practice in New York. Heath focuses his practice on regulatory, compliance, transactional, enforcement and government affairs matters affecting the life sciences industry. He has experience with a broad range of issues, including fraud and abuse laws, drug pricing and reporting, market access, transparency, value-based contracting, HIPAA, etc. He works with numerous clients throughout the drug supply chain and life sciences industry. Heath co-founded and serves on the board of OUTbio: Greater New York, a non-profit dedicated to advancing LGBTQ equality in the life sciences industry and promoting LGBTQ health and wellness in the greater New York region. He received his J.D. and M.A. from Northwestern University.
About Sean Dickson, JD, MPH
Sean Dickson, JD, MPH, is the Senior Vice President of Pharmaceutical Policy and Strategy at AHIP. Prior to AHIP, Sean directed pharmaceutical policy at the West Health Policy Center and led prescription drug research at the Pew Charitable Trusts’ Drug Spending Research Initiative. His policy development and research has been guided by his experience working for both pharmaceutical manufacturers and state governments on issues related to drug pricing, development, and access. During his time in the pharmaceutical industry, he counseled manufacturers on compliance with federal drug price reporting requirements. Sean subsequently supported state public health departments in discount negotiations with drug manufacturers and advising on compliance with federal drug discount program requirements.
Sean has published frequently on prescription drug pricing, including in JAMA Internal MedicineJAMA Health Forum, Journal of Health Politics, Policy, and Law, Journal of Managed Care and Specialty Pharmacy, and Affairs Forefront. He is a frequent commentator on prescription drug policy, offering comments in the New York Times, Washington Post, Bloomberg, Reuters, MarketWatch, STAT, Axios, and Kaiser Health News. He holds a bachelor’s degree in public policy from the University of Chicago and both a master of public health and a law degree from the University of Michigan.
About Seema Kumar
Seema joined Cure Experience in 2022 as the Chief Executive Officer. Prior to Cure, Ms. Kumar spent nearly 20 years at Johnson & Johnson in senior leadership roles, including most recently as the Global Head, Office of Innovation, Global Health and Scientific Engagement, and served on J&J’s Innovation Strategy, Public health leadership and the COVID-19 vaccine steering committee, where she led the company’s external affairs efforts and public education program on COVID and vaccine literacy. Before her tenure at J&J, Ms. Kumar was the Chief of Staff to Dr. Eric Lander and the Chief Communications Officer at the Whitehead Institute/Massachusetts Institute of Technology Center for Genome Research where she played a leadership role in the Human Genome Project. She also has held leadership positions at the U.S. National Institutes of Allergy and Infectious Diseases (NIAID), the National Institutes of Health, and Johns Hopkins School of Medicine. Ms. Kumar holds an M.S. in Science Journalism and Communications from the University of Maryland.